Inhibitors
Antibodies

Primary Antibodies

Invivo Functional Antibodies

Biosimilar Antibodies
Compound Libraries
New Products
Contact Us

GSK2606414 Combination Database

Validated GSK2606414 Combination Schemes—Peer-Reviewed Data Compiled from Primary Literature.

🎯 check GSK2606414 product page

GSK2606414 Combination Database

Please select the combination compounds (Multiple selections allowed)

Please select a combination compound first

Jump to:

GSK2606414 Mechanism of Action: PERK Inhibition in Neuronal Cells Research
GSK2606414: Selectivity & Specificity
GSK2606414 Working Concentration | Cell Culture | Treatment
GSK2606414 Solubility in DMSO
GSK2606414 Molecular Weight | Chemical Structure | Stock Solution
GSK2606414 MedChemExpress (HY-18072)? Try a better option.
GSK2606414 Sigma (508340)? Try a better option.
GSK2606414 Cayman (17376)? Try a better option.
GSK2606414 Tocris (5107)? Try a better option.
GSK2606414 APExBIO (A3448)? Try a better option.
GSK2606414 SDS｜MSDS
GSK2606414 in Neurodegenerative Diseases
GSK2606414 in Oncology and Cancer Research
GSK2606414 in Metabolic Diseases